Bruker BioSciences’ stock reached a new 52-week high of $12.24 this week after the firm announced that it would acquire affiliated company Bruker BioSpin for $914 million (see related article, this issue). Bruker’s shares rose 38.2 percent for the five-day trading week ended Tuesday to lead all gainers in the BCW Index.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.